Tirzepatide Weight Loss Treatment in Montana

The treatment landscape for obesity has changed significantly in recent years, and tirzepatide represents one of the most important advances. As a dual-action medication targeting two key hormonal pathways, tirzepatide has demonstrated remarkable weight loss results in clinical trials — often surpassing those of other GLP-1 medications.

For Montana residents, accessing tirzepatide treatment no longer requires traveling to a specialty clinic. PeakHealth MT provides medically supervised tirzepatide prescriptions through secure telehealth consultations, making this advanced treatment available to patients across the state — from Billings and Missoula to rural communities throughout Montana.

This guide explains how tirzepatide works, what clinical results show, who may qualify, and how to get started with treatment through PeakHealth MT.

What Is Tirzepatide?

Tirzepatide is a dual GIP/GLP-1 receptor agonist — a medication that simultaneously activates two incretin hormone receptors involved in appetite regulation, blood sugar control, and metabolic function. This dual-action mechanism distinguishes tirzepatide from single-target GLP-1 receptor agonists like semaglutide.

The two hormonal pathways tirzepatide targets include:

• GLP-1 (glucagon-like peptide-1): Reduces appetite, slows gastric emptying, and enhances insulin secretion.
• GIP (glucose-dependent insulinotropic polypeptide): Enhances the body's insulin response, supports fat metabolism, and may complement GLP-1 activity for greater overall effect.

Tirzepatide is available under two primary brand names. Zepbound® is FDA-approved specifically for chronic weight management in adults with obesity or overweight with at least one weight-related condition. Mounjaro® is FDA-approved for type 2 diabetes management. At PeakHealth MT, tirzepatide is prescribed for medically appropriate weight management following a thorough clinical evaluation.

Clinical Results and Weight Loss Outcomes

Tirzepatide has produced some of the most impressive weight loss results seen in clinical trials for any obesity medication. In the SURMOUNT-1 trial, participants receiving the highest dose of tirzepatide (15 mg weekly) lost an average of approximately 22.5% of their body weight over 72 weeks when combined with lifestyle modifications.

For a person weighing 250 pounds, that translates to roughly 56 pounds of weight loss over the course of treatment. More than one-third of participants in the highest-dose group lost 25% or more of their body weight.

These results represent a meaningful improvement over other currently available weight loss medications. However, individual outcomes vary based on starting weight, adherence to medication, dietary changes, physical activity, and underlying health conditions.

Most patients begin to see noticeable changes within the first 8–12 weeks, with continued progress as the dose is gradually increased through a structured titration schedule.

Who May Be a Candidate for Tirzepatide?

Tirzepatide is FDA-approved for adults who meet specific medical criteria. You may be a candidate for treatment if you:

• Have a BMI of 30 or greater (obesity)
• Have a BMI of 27 or greater with at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol
• Have struggled with sustained weight management despite diet and exercise efforts
• Are seeking medically supervised support for appetite regulation and metabolic health

Tirzepatide is not appropriate for everyone. Patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) should not take this medication. Your clinician will review your complete medical history, current medications, and laboratory results before determining eligibility. Learn more about who should not take GLP-1 medications.

How Telehealth Weight Loss Treatment Works

PeakHealth MT makes it simple for Montana residents to access tirzepatide treatment without leaving home:

• Schedule an online consultation. Book a secure video visit with your clinician. Onboarding is a one-time $25.
• Complete your medical review. Your clinician will review your health history, current medications, and baseline lab results. Labs can be completed at local facilities such as Labcorp or Quest Diagnostics.
• Individualized plan. If prescription treatment is clinically appropriate, the clinician may send a prescription for tirzepatide to your chosen pharmacy. A prescription is never guaranteed.
• Ongoing follow-up care. The PeakHealth monthly subscription ($99/mo) are scheduled regularly to monitor your progress, adjust dosing through gradual titration, and address any side effects or questions.

All treatment plans are prescribed and monitored by Wesley Hardin, PA-C, with over 15 years of clinical experience in primary care — focused on long-term metabolic health, appetite regulation, and sustainable weight management.

Learn more about how our telehealth process works or review our transparent pricing.

Tirzepatide vs Semaglutide

Both tirzepatide and semaglutide are effective options for medical weight loss, but they differ in mechanism, clinical outcomes, and availability. Here's a side-by-side comparison:

The right choice depends on your medical history, tolerability, insurance coverage, and treatment goals. Your clinician will help determine which option is best suited for you. For a more detailed comparison, read our semaglutide vs tirzepatide guide.

Possible Side Effects

Like all medications, tirzepatide may cause side effects. The most commonly reported are gastrointestinal and typically occur during the initial weeks of treatment or when the dose is increased:

• Nausea
• Diarrhea
• Constipation
• Decreased appetite
• Vomiting
• Abdominal discomfort

These side effects are usually mild to moderate and tend to improve as the body adjusts. PeakHealth MT uses a gradual dose titration approach to minimize discomfort. Your clinician will monitor you closely and adjust your plan as needed.

For a detailed overview, read our guide on common side effects of GLP-1 medications.

Accessing Treatment in Montana

Montana is the fourth-largest state by area, and many residents live hours from the nearest specialty clinic. PeakHealth MT eliminates geographic barriers by delivering tirzepatide treatment entirely through secure telehealth.

• No travel required: Attend appointments from home or anywhere with a reliable internet connection.
• Rural access: Patients in smaller communities receive the same quality of care as those in larger cities.
• Privacy: Consultations are conducted through a secure, HIPAA-compliant platform.
• Continuity of care: Regular follow-up visits ensure your treatment stays on track with consistent clinician oversight.

Whether you're in downtown Billings or a rural community in eastern Montana, you can access medically supervised tirzepatide treatment from PeakHealth MT.

Cities We Serve Across Montana

PeakHealth MT provides tirzepatide treatment to patients throughout Montana via secure telemedicine:

• Billings
• Bozeman
• Missoula
• Helena
• Great Falls
• Kalispell
• Butte
• Whitefish
• Livingston
• Laurel
• Havre
• Miles City
• Sidney
• Glendive

Don't see your community? PeakHealth MT serves all Montana residents through telemedicine.

Interested in semaglutide instead? Learn about semaglutide treatment in Montana or explore our Zepbound® and Wegovy® pages.

Schedule a Telehealth Consultation

If you're a Montana resident considering tirzepatide for weight loss, PeakHealth MT is here to help. Every patient receives a thorough medical evaluation, lab review, and a treatment plan tailored to their specific needs and goals.

Sustainable weight loss is a long-term commitment that requires ongoing clinical management. At PeakHealth MT, you won't just receive a prescription — you'll have a dedicated clinician guiding your progress every step of the way.

Ready to find out if tirzepatide is right for you? Schedule your online consultation today.